← Explore

Low-Intensity Focused Ultrasound Stimulation Ameliorates Working Memory Dysfunctions in Vascular Dementia Rats via Improving Neuronal Environment

Faqi Wang, Qian Wang, Ling Wang, Jing Ren, Xizi Song, Yutao Tian, Chenguang Zheng, Jiajia Yang, Dong Ming

Frontiers in Aging Neuroscience 2022 · 10.3389/fnagi.2022.814560

rodentvascular dementiabehaviourcerebral haemodynamicshistology molecular

Abstract

Working memory impairment is one of the remarkable cognitive dysfunctions induced by vascular dementia (VD), and it is necessary to explore an effective treatment. Recently, low-intensity focused ultrasound stimulation (LIFUS) has been found notable neuroprotective effects on some neurological diseases, including VD. However, whether it could ameliorate VD-induced working memory impairment was still not been clarified. The purpose of this study was to address this issue and the underlying mechanism. We established VD rat model using the bilateral common carotid artery occlusion (BCCAO) and applied the LIFUS (center frequency = 0.5 MHz; I spta = 500 mW/cm 2 , 10 mins/day) to bilateral medial prefrontal cortex (mPFC) for 2 weeks since 2 weeks after the surgery. The main results showed that the LIFUS could significantly improve the performance of VD rats in the specific working memory tasks (delayed nonmatch-to-sample task and step-down task), which might be associated with the improved synaptic function. We also found the improvement in the cerebral blood flow (CBF) and reduced neuroinflammation in mPFC after LIFUS treatment indicated by the inhibition of Toll-like receptor (TLR4)/nuclear factor kappa B (NF-κB) pathway and the decrease of proinflammatory cytokines. The amelioration of CBF and neuroinflammation may promote the living environment of the neurons in VD which then contribute to the survival of neurons and the improvement in synaptic function. Taken together, our findings indicate that LIFUS targeted mPFC can effectively ameliorate reward-based spatial working memory and fear working memory dysfunctions induced by VD via restoring the living environment, survivability, and synaptic functions of the neurons in mPFC of VD rats. This study adds to the evidence that LIFUS could become a promising and non-invasive treatment strategy for the clinical treatment of central nervous system diseases related to cognitive impairments in the future.

Abstract via europepmc.

Speciesrat (Wistar)
Subjects6 animals
Sessions per subject14
Randomisedyes
Blindingnot reported
Sham / controlundescribed
Auditory controlnot reported
Readout timingoffline
Anaesthesiaboth
Readoutsbehaviour, cerebral haemodynamics, histology molecular — delayed nonmatch-to-sample task; step-down task; novel object recognition; elevated plus maze; laser speckle contrast imaging of CBF; HE, Nissl and Golgi-Cox staining; western blot (TLR4, NF-kB, IL-6, JNK, SYP, NR2B, PSD95, CaMKII)
Direction of effectnot assessedNeural excitability was not recorded; LIFUS improved working memory in VD rats, increased vascular branches and synaptic proteins and reduced TLR4/NF-kB pathway proteins and IL-6.
Adverse eventsnone observedBody weight and elevated plus maze anxiety-like behaviour did not differ among groups; authors conclude no weight loss or anxiety-like behaviour was induced.

Exposures

Exposure 1: LIFUS to bilateral mPFC in VD rats

Target: ventromedial prefrontal cortex — “bilateral mPFC”
Device: Olympus / Panametrics · Olympus, Tokyo, Japan · V318 ✓

Pulse timing
Waveformpulsed
Fundamental frequency (kHz)500✓✓✓
Pulse duration (ms)0.3✓✓✓
Pulse repetition frequency (Hz)2,000✓✓✓
Duty cycle (%)not reportedpulse duration × PRF gives 60%⚑
Sonication duration (s)0.5✓✓✓
Pressure and intensity, by domain
Free-field pressure (kPa)not reported
Free-field Isppa (W/cm²)not reported
Free-field Ispta (W/cm²)not reported
In-situ estimatenot reported
In-situ pressure (kPa)not reported
In-situ Isppa (W/cm²)not reported
In-situ Ispta (W/cm²)not reported
Ispta, domain unspecified (W/cm²)0.5✓✓✓⚑
Protocol, in the paper’s words

0.5 MHz, PRF 2.0 kHz, 150 cycles (0.3 ms tone burst), 0.5 s sonication duration, 2 s interstimulus interval, Ispta 500 mW/cm2; 10 min per side per day to bilateral mPFC under 1% isoflurane, daily for 14 days starting 2 weeks after BCCAO.

Flags from extraction

  • n_subjects — Group sizes: CON 8, VD 6, VD+LIFUS 6; n = 6 is the LIFUS group. Some figure legends give VD n = 5 for behaviour.
  • exposures[0].timing.duty_cycle_pct — Duty cycle is not stated.
  • exposures[0].unspecified_domain.ispta_w_cm2 — 500 mW/cm2 converted to W/cm2; domain not stated.
  • sham_type — CON and VD groups 'underwent the same procedures including anesthesia but without LIFUS'; how sham was produced is not described.
  • exposures[0].device.manufacturer — Transducer is an Olympus V318 0.5 MHz immersion transducer; location given as Tokyo, Japan.